Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Pharmaceutical Executive December 1, 2008 George Koroneos	Keeping It Real Between the push by the government for more online security and the addition of new anti-counterfeiting tools, pharma is making headway in the war against brand-jackers and counterfeiters. But it still has a way to go.
Pharmaceutical Executive August 1, 2012	Sunny Outlook for Biopharm 2020? Albert Wertheimer looks beyond today's dark clouds with a comparatively sunny forecast for the biopharm industry in 2020. Just watch out for the harsh light of complacency.
National Defense June 2009 Erwin & Magnuson	7 Deadly Myths About Weapons of Terror Seven noteworthy misconceptions associated with weapons of terror.
Searcher Nov/Dec 2008 Paul Piper	Nets of Terror Terrorist activity on the Internet.
Chemistry World June 21, 2010 Sarah Houlton	Recalling pharma Recent drug withdrawals and manufacturing failures have highlighted the importance of ensuring that the medicines patients take contain what it says on the label.
Parameters Spring 2004 Matthew J. Morgan	The Origins of the New Terrorism A history of terrorism and where it's headed.
IEEE Spectrum September 2006	Nine Cautionary Tales If terrorists decide to strike again, are we prepared? Not really, as these scenarios of extremism make clear: 1. Bomb in a Box... 2. Electroshock... 3. Toxic Train Wreck... 4. Crude Attack... 5. Agro-Armageddon... etc.
BusinessWeek February 7, 2005 Frederik Balfour	Fakes! The global counterfeit business is out of control, targeting everything from computer chips to life-saving medicines. Pick any product from any well-known brand, and chances are there's a counterfeit version of it out there. It's so bad that even China may need to crack down.
IEEE Spectrum May 2006 Pecht & Tiku	Bogus! Electronic manufacturing and consumers confront a rising tide of counterfeit electronics. Feeding this problem is the shift of manufacturing to China, the growing sophistication of technology, and the rise of the Internet as a marketplace.
IndustryWeek May 1, 2007 Jill Jusko	Supply Chain Management: Foiling Fakes Counterfeit products are depriving manufacturers of revenue, harming brand integrity and in some cases, compromising safety. Manufacturers are fighting to keep phony goods out of their supply chains.
Pharmaceutical Executive November 1, 2011 Jill Wechsler	The Drug Shortages Struggle Clamor for critical therapies prompts probes of prices, production practices.
Salon.com September 12, 2000 Arthur Allen	The battle over bio-terror A recent report urges America to pour $13 billion into preventing disease-based warfare, but evidence suggests that our fears are misplaced.
Pharmaceutical Executive January 21, 2014 William Looney	Russia's Bet on Biopharma Can innovation trump ideology? Russia faces a stark choice in betting on the visible hand of government in promoting a "world class" biopharmaceutical sector
Pharmaceutical Executive November 1, 2006 Sarah Houlton	Global Report: 'Bout Time The European Union has been late to enter the fight against counterfeiting. Fed up, Parliament has passed a proposal designed to give its countries the nudge they need.
Pharmaceutical Executive September 1, 2012 Stan Bernard	The Payer C Change: From Customers to Competitors "Payers have evolved to become powerful global contenders with pharma for increasingly limited funding of drug budgets." Understanding why and how this payer shift to dominance occurred is critical for pharmaceutical professionals in adjusting their business model.
PC World May 2001 Kim Zetter	Hacker Nation Shadowy, computer-wise predators slip in undetected to steal data, deface Web sites, crash systems--or just look around. We talk to some current and former hackers to find out more about them and what they're after...
Chemistry World May 18, 2007 Hepeng Jia	China's Battle with Fake Drugs While China's pharmaceutical industry is experiencing rapid growth, a boom in counterfeit drugs is costing human lives and eroding the public's confidence in medical products.
National Defense September 2010 Eric Beidel	Social Scientists and Mathematicians Join The Hunt for Terrorists Internet chat rooms and other online discussion forums supplement, and in some cases, have replaced mosques, community centers and coffee shops as meeting spots for jihadists, experts say.
Pharmaceutical Executive July 3, 2007	Harbingers of Change What to watch, and watch out for, in the bottom half of '07. The IMS Health Editorial Board identifies what it believes are the key events that will impact the global pharmaceutical market in the near future.
Pharmaceutical Executive September 1, 2008	How Do You Solve a Problem Like Manufacturing? Outsourcing saves pharmaceutical companies money -- except when it doesn't. Here's how to decide what to do.
Pharmaceutical Executive February 1, 2011 Jon Zifferblat	China: Business as UNusual If there is one market that requires a click on the 'refresh' button, it's China. General Biologic provides a snapshot of what's ahead for Big Pharma in the country
Investment Advisor June 2008 Irace & Mehta	Security in a New Age How to protect your firm from 21st century online criminals
BusinessWeek December 13, 2004 Bruce Einhorn	Go East, Big Pharma Drugmakers are expanding in China, but patents are still a worry.
Pharmaceutical Executive December 1, 2010 Zhu Shen	China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda
Pharmaceutical Executive July 1, 2013 Jill Wechsler	Seeking Supply Chain Security FDA wants pharma leaders to do more to ensure drug quality at home and abroad.
Pharmaceutical Executive July 1, 2005 Jill Wechsler	Washington Report: The e-Bandwagon The federal government is driving e-Rx adoption by establishing standards that Medicare drug plans will have to adopt by 2009, and HHS officials are pushing to make this happen much earlier.
Pharmaceutical Executive April 1, 2012 Jill Wechsler	Shortages and Sunshine Disclosure rules the day, as industry confronts demands to report supply problems, results of clinical trials, and payment to doctors.
Reason April 2001 Ronald Bailey	Goddamn the Pusher Man Why does everybody seem to hate the pharmaceutical industry?
BusinessWeek October 18, 2004 Catherine Arnst	The Waning of the Blockbuster Drug What's promising now are drugs that target niche diseases. That means painful restructuring ahead for Big Pharma
Pharmaceutical Executive January 1, 2007 Jill Wechsler	Washington Report: A Full Plate It's going to be a busy year in Washington for the pharmaceutical industry. Drug safety, unapproved uses, e-data requirements, and a shift to personalized medicine are just a few of the hot issues on tap for 2007.
IndustryWeek November 1, 2007 Jonathan Katz	The Great Supply Chain Robbery Manufacturers are leveraging the latest advances in security technology to stay one step ahead of the bad guys.
Pharmaceutical Executive January 1, 2012 Jill Wechsler	New Year, New Issues Look for action in 2012 on drug access, shortages, innovation, and transparency. The 800-pound gorilla in the room is the looming Supreme Court decision on the constitutionality of the Obama health reform legislation.
Chemistry World January 6, 2014 Sarah Houlton	Weathering the storm Pharma is in the middle of a strategic crisis, if a report published at the start of 2013 by Roland Berger Strategy Consultants is to be believed.
CFO June 1, 2008 Randy Myers	Counter Attack As phony goods flood the market, companies fight to protect their brands. The U.S. Customs and Border Protection agency blames counterfeit merchandise for the loss of more than 750,000 American jobs.
Information Today February 4, 2013 Paula J. Hane	A Cyber War Is Brewing A cyberwar has been brewing and although you might view this battle as governments going head to head in a shadow fight, experts say the battleground is shifting from government entities to the private sector, to civilian targets that provide many essential services to U.S. citizens.
Pharmaceutical Executive June 1, 2011	Emerging Pharma Leaders 2011 Meet 2011's Emerging Pharma Leaders. Can these 30 trendsetters build competitive scale from scarcity?
National Defense February 2009 Magnuson & Rusling	Senators May Seek Life Science Lab Security Regulations Life science laboratories, and similar facilities are proliferating throughout the world. Security is lax at many of them -- including the United States. Background checks for those working in the labs are spotty.
IEEE Spectrum September 2006 Charles Perrow	Shrink The Targets Human nature can better withstand a dozen small disasters than a single great one, even if the casualty total is the same. Protecting America's big targets is next to impossible; we should instead downsize them to make them less consequential and easier to protect.
Military & Aerospace Electronics June 2006 Allan Whitlow	Integrators Must Take Measures to Protect Themselves From Counterfeit Electronic Parts Counterfeit electronic parts, which have come to the forefront in the electronics manufacturing industry in recent months, are particularly vexing to high-reliability manufacturers of military and aerospace products where component failure is not an option.
Pharmaceutical Executive September 1, 2013 William Looney	High Noon For Hot Markets Fading growth, overstretched governments, and a global governance backlash against pharma business are turning up the heat on the performance of emerging country markets.
Pharmaceutical Executive January 1, 2007 Glass & Poli	Forecast 2007: Connecting the Dots How do execs rank the issues facing the pharmaceutical industry? And what are the links they see between them? A new study reveals the industry's mental map of today's challenges.
BusinessWeek February 9, 2004 Charles Haddad	Fake Drugs, Real Disaster As operators get more canny, the FDA is cracking down on counterfeit medicine.
Managed Care February 2002 Ira Studin	Reframing the Pharmaceutical Manufacturer/Health Plan Relationship in Managed Care It is suggested that health plans address "total cost-of-care savings" in their budget process, and the pharmaceutical manufacturers establish a "consultative service function" in their managed care divisions...
Pharmaceutical Executive March 1, 2009 Porth & Sillup	Fifth Annual Press Audit: Safety in the Spotlight Reporters pass on the typical litany of lightning-rod issues and instead devote more than three-quarters of all coverage in 2008 to drug safety and the regulators who enforce it.
Chemistry World January 3, 2013 Sarah Houlton	2012 pharma industry roundup It may have been a relatively quiet year in terms of mergers and acquisitions, but the pharma industry nonetheless made plenty of headlines in 2012.
The Motley Fool September 9, 2004 Charly Travers	The Case for Drug Stocks The reports of the drug industry's death are greatly exaggerated.
The Motley Fool February 21, 2008 Brian Lawler	A Bit of Irony From the FDA The agency has a mixed message on drug importation, as evidenced in the recent possible contamination of China-produced Heparin.
Pharmaceutical Executive July 1, 2014 Jill Wechsler	Pre-emption and States' Rights Pharma backs federal standards for compassionate use, drug importing, data transparency, and track-and-trace.
Pharmaceutical Executive January 1, 2011	The Steep, Slow Climb A survey of leading experts reveals 2011's sobering reality and the trends that smart drugmakers will follow into the next decade.
Pharmaceutical Executive July 1, 2013 William Looney	Talent, Terror, and the Turnaround We offer news on 15 new Emerging Pharma Leaders, business innovation, and terrorism threats to the pharmaceutical industry.